Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Annexon, Inc. (Nasdaq: ANNX) will have its president and CEO, Douglas Love, participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on April 10, 2024. The company is focused on developing novel therapies for complement-mediated neuroinflammatory diseases. The event will be webcast live and available for replay on the Annexon website.

BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, president and chief executive officer, will participate in a fireside chat at the 23^rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 11:00 a.m. ET.

A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.

About Annexon

Annexon Biosciences (Nasdaq: ANNX) is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Annexon’s novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, Annexon is rigorously advancing its mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. To learn more visit annexonbio.com.

Investor Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Media Contact:
Sheryl Seapy
Real Chemistry
949-903-4750
sseapy@realchemistry.com

FAQ

When is the 23rd Annual Needham Virtual Healthcare Conference taking place for Annexon, Inc. (ANNX)?

The conference will be held on April 10, 2024.

Who will be participating in the fireside chat at the conference for Annexon, Inc. (ANNX)?

Douglas Love, the president and chief executive officer of Annexon, Inc., will be participating in the fireside chat.

Where can the live webcast of the event be accessed for Annexon, Inc. (ANNX)?

The live webcast can be accessed under the 'Events & Presentations' section on the Investors page at www.annexonbio.com.

How long will the replay of the webcast be available for Annexon, Inc. (ANNX)?

The replay of the webcast will be archived on the Annexon website for 30 days following the presentation.